SWAN Genomics, an early stage startup focused on commercializing an innovative new approach to DNA sequencing, has secured $6.0M in Series A funding. The capital infusion will accelerate the company's mission to deliver more accessible genomics data to existing and new markets.
The multi-disciplinary firm is developing novel methods designed to broaden access to genomic insights. This latest investment underscores the potential of SWAN Genomics' technology as it moves to bring its advanced sequencing solutions to market.
















